ESCITALOPRAM: payments to doctors
Payments that named ESCITALOPRAM as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $86K
- Providers
- 7
- Transactions
- 39
- Average per transaction
- $2,215
The per-transaction average — $2,215 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7 providers the average total is $12,340, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| H. Lundbeck A S | $86,361 | 100.0% |
| Almatica Pharma LLC | $17 | 0.0% |